Management of Low Mean Corpuscular Hemoglobin Concentration (MCHC)

Diagnostic Approach

Low MCHC (below 27 g/dL) is a key indicator of inadequate hemoglobin synthesis, often occurring before changes in MCV become apparent in early iron deficiency, according to the Kidney International Supplements 1
Complete blood count analysis should include evaluation of other parameters: hemoglobin, MCV, MCH, RDW, and reticulocyte count to properly classify the anemia, as recommended by the Kidney International Supplements 1
Iron studies are essential for diagnosis and should include serum ferritin, transferrin saturation, and serum iron levels, as stated by the Journal of Crohn's and Colitis 3
Diagnostic criteria for iron deficiency depend on inflammation status:
- Without inflammation: serum ferritin < 30 μg/L confirms iron deficiency, according to the Journal of Crohn's and Colitis 3
- With inflammation: serum ferritin up to 100 μg/L may still indicate iron deficiency, as noted by the Journal of Crohn's and Colitis 3
- Transferrin saturation < 20% with ferritin > 100 μg/L suggests anemia of chronic disease, as stated by the Journal of Crohn's and Colitis 3

Iron deficiency anemia is the most common cause of low MCHC, as reported by Gut 4
Anemia of chronic disease, particularly in patients with inflammatory conditions, is a possible cause of low MCHC, according to the Journal of Crohn's and Colitis 3
Combined deficiency states (iron deficiency with concurrent B12 or folate deficiency) can also cause low MCHC, as noted by the Kidney International Supplements 1
Hemoglobinopathies (thalassemia, sickle cell disease) can present with low MCHC, as reported by Gut 4

In adult men and post-menopausal women, gastrointestinal evaluation is mandatory as GI blood loss is the most common cause, according to Gut 4
Upper endoscopy and colonoscopy should be performed to exclude GI malignancy, as recommended by Gut 4
Small bowel biopsy during endoscopy to rule out celiac disease, as stated by Gut 4
In pre-menopausal women, menstrual blood loss assessment is important, as noted by Gut 4
Evaluate for malabsorption, particularly in patients with gastrointestinal symptoms, as recommended by Gut 4
Screen for NSAID use, which can cause occult GI bleeding, according to Gut 4
Consider chronic kidney disease, which is associated with anemia, as stated by the Kidney International Supplements 1 and Circulation 5

Address the underlying cause of iron deficiency, as recommended by Gut 4
Iron supplementation is recommended for all patients with confirmed iron deficiency, according to the Journal of Crohn's and Colitis 3
Oral iron therapy is the first-line treatment for most patients, as stated by the Journal of Crohn's and Colitis 3
Continue oral iron therapy for 3-6 months after normalization of hemoglobin to replenish iron stores, as recommended by the Journal of Crohn's and Colitis 3
Intravenous iron should be considered in patients with malabsorption, patients with inflammatory bowel disease, or when rapid repletion is needed, as noted by the Journal of Crohn's and Colitis 3 and Circulation 5
Total iron requirement can be estimated based on hemoglobin level and body weight, as stated by the Journal of Crohn's and Colitis 3

Repeat CBC after 4-8 weeks of treatment to assess response, as recommended by the Journal of Crohn's and Colitis 2 is not used, instead: Repeat CBC after 4-8 weeks of treatment to assess response, according to the American College of Physicians 2 is not used, instead: the guideline society is not available for this reference, however, the information is: Repeat CBC after 4-8 weeks of treatment to assess response 2
Monitor serum ferritin to ensure adequate repletion of iron stores, as stated by the Journal of Crohn's and Colitis 2 is not used, instead: the guideline society is not available for this reference, however, the information is: Monitor serum ferritin to ensure adequate repletion of iron stores 2
For patients with persistent or recurrent iron deficiency: Reassess compliance with therapy, as recommended by the Journal of Crohn's and Colitis 2 is not used, instead: the guideline society is not available for this reference, however, the information is: Reassess compliance with therapy 2
Consider repeat endoscopic evaluation, as stated by Gut 4
Evaluate for occult sources of blood loss, as recommended by Gut 4

Low MCHC with normal MCV may represent early iron deficiency before microcytosis develops, as noted by the Journal of Crohn's and Colitis 2 is not used, instead: the guideline society is not available for this reference, however, the information is: Low MCHC with normal MCV may represent early iron deficiency before microcytosis develops 2
Serum ferritin can be falsely elevated in inflammatory states, making diagnosis challenging, as stated by the Journal of Crohn's and Colitis 3
In patients with chronic kidney disease, anemia management should follow specific guidelines for this population, according to the Kidney International Supplements 1 and Circulation 5
In patients with cancer, anemia management should consider disease-specific factors and treatment effects, as recommended by the European Society for Medical Oncology, as stated by Annals of Oncology 6